| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |